Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05176119
Other study ID # MS 160/2021
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date March 25, 2021
Est. completion date June 25, 2021

Study information

Verified date December 2021
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The effect of low dose nalbuphine or ketamine in the prevention of emergence agitation after sevoflurane anesthesia in children undergoing tonsillectomy with or without adenoidectomy. This randomized double-blind study was carried out at, Ain shams University Hospitals, from March 2021 to June 2021 on 90 patients after approval of the ethical committee.


Description:

Emergence agitation (EA) in children is increased after sevoflurane anesthesia. Nalbuphine and midazolam have been used for prophylactic treatment with controversial results. Patients and Methods:Totally, 90 children between 4 and 10 years of age and of American Society of Anesthesiologists I-II undergoing adenotonsillectomy under sevoflurane-based anesthesia were enrolled in the study. Children were randomly allocated to one of the three groups: Group N received nalbuphine 0.1 mg/kg, Group K received ketamine 0.25 mg /kg and Group S received the equivalent volume saline. The study medications was given after discontinuation of sevoflurane by the end of surgery. In the post anesthesia care unit emergence agitation was assessed with emergence agitation scale upon admission (T0), after 5 min (T5), 10 min (T10), 15 min (T15), 20 min (T20), 25 min (T25) and 30 min (T30).


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date June 25, 2021
Est. primary completion date June 25, 2021
Accepts healthy volunteers No
Gender All
Age group 4 Years to 10 Years
Eligibility Inclusion Criteria: Pediatric patients undergoing tonsillectomy with or without adenoidectomy 1. Age 4 - 10 years. 2. Sex: Both sexes 3. Patients with ASA classificaion I and II. Exclusion Criteria: 1. Declining to give written informed consent. 2. History of allergy to the medications used in the study. 3. psychiatric disorder. 4. ASA classification III-V. 5. Fever ,cough , asthma or upper respiratory tract infection . 6. Anticipated difficult airway . 7. Hearing defect . 8. Neurological disorder. 9. Family history of malignant hyperthermia .

Study Design


Intervention

Drug:
Nalbuphine Injection
At the end of the surgery and just before discontinuation of sevoflurane and extubation the study medications will be prepared by the local pharmacy as 10 ml syringes that were handed to the anesthesiologist in charge in OR room who was blinded to the nature of the medications.
Ketamine
At the end of the surgery and just before discontinuation of sevoflurane and extubation the study medications will be prepared by the local pharmacy as 10 ml syringes that were handed to the anesthesiologist in charge in OR room who was blinded to the nature of the medications.
Saline
At the end of the surgery and just before discontinuation of sevoflurane and extubation the study medications will be prepared by the local pharmacy as 10 ml syringes that were handed to the anesthesiologist in charge in OR room who was blinded to the nature of the medications.

Locations

Country Name City State
Egypt Ain Shams university hospitals Cairo Al Abbassia

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Emergence Agitation 5 step Emergence Agitation scale: describing change in mental status of the children during emergence from general anesthesia. The minimum value is 1 and maximum value is 5, and higher scores mean a better outcome.
Score 1 Obtunded with no response to stimulation. Score 2 Asleep but responsive to movement or stimulation Score 3 Awake and responsive Score 4 Crying Score 5 Thrashing behaviour that requires restraint
At Time zero (The time of extubation)
Secondary Emergence Agitation at post anesthesia care unit(PACU) 5 step Emergence Agitation scale: describing change in mental status of the children during emergence from general anesthesia. The minimum value is 1 and maximum value is 5, and higher scores mean a better outcome.
Score 1 Obtunded with no response to stimulation. Score 2 Asleep but responsive to movement or stimulation Score 3 Awake and responsive Score 4 Crying Score 5 Thrashing behaviour that requires restraint
At time of delivery to PACU
Secondary Post-operative pain Occurrence of post-operative pain using Modified Children's Hospital of Eastern Ontario Pain Scale (mCHEOPS). It is a behavioral observational Pain Scale for evaluating postoperative pain in young children. It can be used to monitor the effectiveness of interventions for reducing the pain and discomfort. The minimum value is 0 and maximum value is 10, and higher scores mean a worse condition. 30 minutes
Secondary Midazolam given for emergence agitation It is described as given or not given. 30 minutes
Secondary Duration in PACU duration from receiving the patient in the post anaesthesia care unit till discharge to the ward.it described in the form of minutes. 45 minutes
Secondary Time to hospital discharge. Duration from receiving the patient in the post anesthesia care unit till hospital discharge.it described in the form of hours. 6 hours
Secondary Occurrence of postoperative nausea and vomiting described in the from of occurred or not occurred 120 minutes
Secondary Occurrence of laryngeal spasm described in the from of occurred or not occurred 120 minutes
Secondary Post-tonsillectomy bleeding. described in the from of occurred or not occurred 120 minutes
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05818644 - Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
Not yet recruiting NCT06018324 - CloudCare in the Treatment of Type 1 Diabetes in Pediatrics
Not yet recruiting NCT04523623 - Pain Control Differences Between Oxycodone and Ibuprofen in Children With Isolated Forearm Injuries N/A
Completed NCT02930850 - Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation N/A
Completed NCT03385681 - Pediatric Pain Management - an Intervention Study N/A
Completed NCT00229671 - Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics N/A
Completed NCT04465370 - Pediatric Cardiac Output Monitoring Observational Study
Recruiting NCT04100070 - Intensive Versus Standard One Year Monitoring on Glycaemic Control After Initiating CSII in Children With DT1. DEEP Study N/A
Not yet recruiting NCT06035757 - The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery Phase 4
Completed NCT03369847 - Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge Phase 4
Completed NCT05474170 - Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest N/A
Recruiting NCT05230004 - Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth N/A
Completed NCT05731401 - Expressed Beliefs About the Cause of Pain in a Paediatric Population
Completed NCT05818215 - Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
Completed NCT06376188 - Improving Breaking Bad News in Pediatrics by Simulated Communication N/A
Completed NCT04589910 - Measuring Thickness of the Normal Diaphragm in Children Via Ultrasound. N/A
Recruiting NCT04252508 - Impact of a Double-reading Animated Film (Child, Parents) in Preoperative on the Anxiety of Children Upon Arrival at the Operating Room N/A
Completed NCT04655378 - Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura
Completed NCT04610918 - Comparing Body Composition Assessment Methods
Completed NCT03964259 - Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia Phase 1